Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Chiara Gelmi

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|April 19, 2024
Uveal melanoma: Current evidence on prognosis, treatment and potential developmentsMaria Chiara Gelmi, Martine J Jager
International Ophthalmology|March 4, 2018
Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosisMario Fruschelli, Marco Capozzoli, Maria Chiara Gelmi, et al.
International Journal of Molecular Sciences|June 10, 2022
MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate BalanceMaria Chiara Gelmi, Laurien E Houtzagers, Thomas Strub, et al.
Ocular Oncology and Pathology|January 15, 2021
Orbital Pseudocellulitis: A Retinoblastoma-Associated Masquerade SyndromeFrancesco Martino, Maria Chiara Gelmi, Paolo Galluzzi, et al.
Ophthalmology|November 18, 2021
Adding the Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System Offers More Precise Prognostication in Uveal MelanomaMaria Chiara Gelmi, Zeynep Bas, Kabir Malkani, et al.
Ophthalmology|April 18, 2022
ReplyMaria Chiara Gelmi, Zeynep Bas, Kabir Malkani, et al.
Acta Ophthalmologica|July 24, 2025
Tumour progression shows decrease in PD-L1 expression in matched metastases/primary uveal melanomasMaria Chiara Gelmi, Gulçin Gezgin, Ellen Kapiteijn, et al.
Melanoma Research|July 19, 2023
Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanomaKseniya A Glinkina, Amina F A S Teunisse, Maria Chiara Gelmi, et al.
Investigative Ophthalmology & Visual Science|December 27, 2023
PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal MelanomaMaria Chiara Gelmi, Gulçin Gezgin, Pieter A van der Velden, et al.
Investigative Ophthalmology & Visual Science|December 14, 2022
Preclinical Evaluation of Trabectedin in Combination With Targeted Inhibitors for Treatment of Metastatic Uveal MelanomaKseniya Glinkina, Fariba Nemati, Amina F A S Teunisse, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|April 19, 2024
Uveal melanoma: Current evidence on prognosis, treatment and potential developmentsMaria Chiara Gelmi, Martine J Jager
International Ophthalmology|March 4, 2018
Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosisMario Fruschelli, Marco Capozzoli, Maria Chiara Gelmi, et al.
International Journal of Molecular Sciences|June 10, 2022
MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate BalanceMaria Chiara Gelmi, Laurien E Houtzagers, Thomas Strub, et al.
Ocular Oncology and Pathology|January 15, 2021
Orbital Pseudocellulitis: A Retinoblastoma-Associated Masquerade SyndromeFrancesco Martino, Maria Chiara Gelmi, Paolo Galluzzi, et al.
Ophthalmology|November 18, 2021
Adding the Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System Offers More Precise Prognostication in Uveal MelanomaMaria Chiara Gelmi, Zeynep Bas, Kabir Malkani, et al.
Ophthalmology|April 18, 2022
ReplyMaria Chiara Gelmi, Zeynep Bas, Kabir Malkani, et al.
Acta Ophthalmologica|July 24, 2025
Tumour progression shows decrease in PD-L1 expression in matched metastases/primary uveal melanomasMaria Chiara Gelmi, Gulçin Gezgin, Ellen Kapiteijn, et al.
Melanoma Research|July 19, 2023
Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanomaKseniya A Glinkina, Amina F A S Teunisse, Maria Chiara Gelmi, et al.
Investigative Ophthalmology & Visual Science|December 27, 2023
PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal MelanomaMaria Chiara Gelmi, Gulçin Gezgin, Pieter A van der Velden, et al.
Investigative Ophthalmology & Visual Science|December 14, 2022
Preclinical Evaluation of Trabectedin in Combination With Targeted Inhibitors for Treatment of Metastatic Uveal MelanomaKseniya Glinkina, Fariba Nemati, Amina F A S Teunisse, et al.
Pageof 2